Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer now identifies the website as revision v3.8.0 instead of v3.7.2.
    Difference
    0.0%
    Check dated 2026-11-02T23:48:10.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    An NIH transition announcement appears on the page, directing visitors to updates and FAQs and noting that both “Super Intelligence” and “Artificial Intelligence” may appear during the transition.
    Difference
    0.1%
    Check dated 2026-10-26T23:46:34.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-20T00:00:00.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-13T05:53:10.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The study record history adds a new version documenting a study-status update, replacing an earlier listed date. The specific status change is not shown here.
    Difference
    0.1%
    Check dated 2026-10-05T23:45:20.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The study history now includes a new version entry for 2026-09-21 introducing Conditions and Study Status with Revision: v3.7.0, and the prior revision reference v3.6.6 dated 2026-08-04 was removed.
    Difference
    0.1%
    Check dated 2026-09-21T23:55:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.